Please assess the completion status of the following clinical trial:

Trial Title: ConsultaTM CRT-D Clinical Evaluation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have an indication for a defibrillator.~* Patients who are optimally treated with medication.~* Patients who are New York Heart Association (NYHA) Class III or IV~Exclusion Criteria:~* Patients with a life expectancy less than the duration of the study.~* Patients with medical conditions that preclude the testing required for all patients by the study protocol or that otherwise limit study participation required for all patients.~* Patients with mechanical tricuspid heart valves.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Implantation of Consulta CRT-D (Type: EXPERIMENTAL): Patients have an implant attempt with a Bi-ventricular Implantable Cardioverter Defibrillator

Based on this trial design, predict the completion outcome and termination type (if applicable).